Breast Cancer Awareness Programme

A "National Cancer Grid' initiative by TMC. To locate centre closer to your home click here.

Director's Message

The Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) has achieved a seamless integration of basic and clinical research, and has evolved as a comprehensive Cancer Centre in Navi Mumbai. In its verdant 60 acre campus lie the Cancer Research Institute (CRI) and the Clinical Research Institute (CRC) that provide a multidisciplinary approach to cancer research and patient care. With a 116 bed hospital equipped with state-of-the-art technology, and 19 Principal Investigator (PI) - led research groups, ACTREC has established itself as a unique model for translational research.

Dr. S.V.CHIPLUNKAR
Director - ACTREC

The Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) is the state-of-the-art R&D satellite of the Tata Memorial Centre (TMC), which also includes under its umbrella the Tata Memorial Hospital (TMH), the largest cancer hospital in Asia. ACTREC has the mandate to function as a national centre for treatment, research and education in cancer. TMC is an autonomous grant-in-aid institution of the Department of Atomic Energy (DAE), Government of India. It is registered under the Societies Registration Act (1860) and the Bombay Public Trust Act (1950). Its Governing Council is headed by the Chairman, Atomic Energy Commission, Government of India.

ACTREC comprises of 2 arms - one for basic research and another for clinical research. The basic research building was inaugurated in March 2002 at the new site of ACTREC in Kharghar, Navi Mumbai. In August 2002, the Cancer Research Institute (CRI) shifted in toto from its Parel campus in Mumbai to serve as the basic research arm of ACTREC. The clinical research arm of ACTREC comprising of the Clinical Research Centre (CRC) became functional from March 2005. ACTREC also has a 100-bed hospital fully equipped with state-of-the-art diagnostic and therapeutic facilities. Research investigations at CRI currently focus on molecular mechanisms responsible for causation of major human cancers relevant to India. It is envisaged that in the future, ACTREC will play a greater role in drug development and emerging therapies for treatment and prevention of cancer.

Khanolkar Shodhika

Scientists in CRI undertake multi-pronged investigations into cancer biology, which address basic, and translational research queries using human tumors, experimental animals and cells in culture, with an aim to provide the tools for chemoprevention, early diagnosis, prognosis and therapy.

Paymaster Shodhika

The Clinical Research Centre (CRC), which has been envisaged as a 'model centre for clinical research' was formally inaugurated on the 30th of March 2005 by Dr. Anil Kakodkar, Chairman, Atomic Energy Commission.